HIGHLIGHTS
- who: Ziyue Yang et al. from the Department of Blood Transfusion, Xiangya Hospital, Central South University, Xiangya Road, Changsha, Hunan Province, China have published the research work: Pancancer Analysis of the Prognostic and Immunotherapeutic Value of Progestin and AdipoQ Receptor 4, in the Journal: Computational and Mathematical Methods in Medicine of 17/Dec/2022
- what: The analysis focuses on FDA-approved or clinically tested drugs. The research provided a significant correlation between PAQR4 expression and the tumors purity in 18 cancers, especially in THYM and BLCA, where higher PAQR4 was associated with lower tumor purity . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.